top of page
Case Studies & Blogs
If You’re Still Debating RWE, You’re Already Behind
A summary of the new position paper on the use of RWE by FDA authors
Aug 11, 20253 min read
The Fast Lane to Evidence? What the New EMA Report Means for Trial Emulation
The European Medicines Agency (EMA) just released its third annual report on real-world evidence (RWE) in regulatory decision-making and...
Jul 7, 20253 min read
The Trouble with Comparators: Fixing External Control Arms with Trial Emulation
Real-world evidence is becoming central to regulatory and HTA decision-making in rare diseases and it is so for good reason. In many rare...
Jul 1, 20253 min read
bottom of page